FNIH Privacy Policy

Print

Updated: 5/30/2003

Of the information we learn about you from your visit to "FNIH.org," we store only the following: the domain name from which you access the Internet, the date and time you access our site, and the Internet address of the web site from which you direct-linked to our site. This information is used to measure the number of visitors to the various sections of our site and to help us make our site more useful to visitors. Unless it is specifically stated otherwise, no additional information will be collected about you.
When inquiries are E-mailed to us, we store the question and the E-mail address information so that we can respond electronically. Unless otherwise required by statute, we do not identify publicly who sends questions or comments to our web site. We will not obtain information that will allow us to personally identify you when you visit our site, unless you chose to provide such information to us.

About "Cookies"

While visiting sites within the FNIH.org domain, you may occasionally encounter a Web page that employs "cookies". A cookie is a small file that a Web site transfers to your computer's hard disk allowing our server to "remember" specific information about your session while you are connected.

Requests to send cookies from FNIH Web pages are not designed to collect information about you, but only about your browser "session." The cookie makes it easier for you to use the dynamic features of these Web pages. The cookie and the information about your session will be destroyed automatically shortly after you close your browser--it is not permanently stored on your computer. Unless an FNIH web page specifically notifies you otherwise, we will not collect and maintain personal information about you.

To protect your privacy, be sure to close your browser completely after you have finished conducting business with a Web site that uses cookies. If you are concerned about the potential use of information gathered from your computer by cookies, you can set your browser to prompt you before it accepts a cookie. Most Internet browsers have settings that let you identify and/or reject cookies.

Questions about Foundation for NIH privacy policies should be sent to .

  • About Biomarkers

    Biomarkers are characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic intervention. More

  • Join Us

    Become a Member
    Learn how you can join and support The Biomarkers Consortium.

    The Biomarkers Consortium embraces government, industry, patient advocacy groups, and non-profit organizations, each of which has a stake in the development of biomarker technology.

  • Latest News

    THE BIOMARKERS CONSORTIUM LAUNCHES I-SPY 2 BREAST CANCER CLINICAL TRIAL:  Click here to read the press release.

    March 17, 2010 -- Announcing the launch of the Biomarkers Consortium I-SPY 2 TRIAL (Investigation of Serial studies to Predict Your Therapeutic Response with Imaging and moLecular analysis): An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy), which is taking place today from 9-10:30 a.m. ET at the National Press Club, Washington, DC.  Click here for more information.

    View the Web Cast

     

    Six awardees conducting data analysis to Develop Clinical Criteria for the Diagnosis of Clinically Important Weakness Associated with Low Muscle Mass in Older Adults: Click here to read

    The Metabolic Disorders Steering Committee releases strategy for Mathematical Modeling in Atherosclerosis:  Details

    PRESS RELEASE:  The Biomarkers Consortium Completes First Project to Show That Adiponectin is a Predictive Biomarker for Type 2 Diabetes:  Click here to read

    RFP for Data Analysis to Develop Clinical Criteria for the Diagnosis of Clinically Important Weakness Associated with Low Muscle Mass in Older Adults.  Due Date: September 8, 2009.  Click here to read.

     

    Available Now: The Biomarkers Consortium Report, Volume 1, Issue 1, May 2009. Click Here to Read

    The Metabolic Disorders Steering Committee Prioritized Areas of Unmet Need: As advertised in Volume 58, No. 4, April 2009 issue of Diabetes.  Click Here to read.

    Presentations Available from the Beta Cell Function Symposium. Click here for agenda.